News
Where We Will Be Exhibiting 2023
2023 106th Oxford Ophthalmological Congress
New Theatre, Worcester College and Randolph Hotel
Stand 14
3rd, 4th and 5th July 2023
Click here to register
MOS AGM Meeting
Austin Court, Cambridge Street, Birmingham
Friday 6th October 2023
View programme / Register
UKISCRS 47th Annual Meeting
Leonardo City Hotel, London Bridge
1st, 2nd and 3rd November 2023
BMEH Bicentennial Scientific Conference
ICC Birmingham
7th to 8th December 2023
Click here to register
Sightcare Business Conference 2024
Telford International Centre
28th to 29th January 2024
Click here to book now
100% Optical
EXCEL, London
24th to 26th February 2024
Click here to register
Blogs
Spanish Healthy LivingA well known antioxidant used to supplement eye health called lutein, has been the topic of a small research event by Spanish researchers who have been studying the high antioxidant levels of native extra virgin olive oil.Lutein has long been associated with the the maintenance of healthy eyes and extra virgin olive oil has always had a high levels of an |
Costly but ClearFor sufferers of long sightedness, and wearers of glasses, a new plastic lens is promising to slash the percentage of those still needing corrective lenses following a relatively simple surgical procedure.The procedure itself sounds gruesome as it involves cutting the lens of the eye with an incision ( but it is just three millimeters long) and then the p |
Tears over WineTrying to see anything clearly when you've participated in a little too much social drinking is the norm, but scientists have now recorded as fact that drinking alcohol has a marked detriment on your night vision as it increases the human perception of luminous circles or 'halos'.Scientists from the University of Granada have proven that our consumption o |
Stay ShadedWhile we are advised to wear sunglasses throughout the year for protection from UV rays in sunshine and snow, there is a percentage of the population that have to wear protective eye wear all of the time due to an eye condition called Aniridia. |
Exploring the LinksAs a by- product of research made by Boston Research teams developing human stem cells to grow human corneas, further information was released that will assist in the further research of Alzheimers disease.While looking in detail at the human retina, researchers have focused on the nerve fibres of the retina and have revealed that the thickness of the ner |
Stem Cell BreakthroughBurns victims and chemical injury patients along with diagnosed damaging eye disease patients may benefit from new research breakthroughs founded by the Massachusetts Eye and ear and Schepens Eye Research Institute who have collaborated with the VA Boston Healthcare System and Boston Childrens Hospital.Together the research study have constructed tissue f |
Satellite DiagnosisIn the United States medical staff are researching the use of remote screening to detect retinopathy of prematurity. |
Stroke Marker?A super cheap eye test has become available that examines in detail the retina of each eye. But the interest for medical professionals is that research is throwing up some interesting facts regarding sufferers of hypertensive retinopathy and the link with the increased risk of having a stroke. |
Myopia ConcernWorrying results from a British Medical School have reported that the number of cases of reported Myopia are on the increase. |
BreakthroughResearch in the area of cancer is always ongoing and breakthroughs can effect many or one type of cancer. |
Lessen The LightAn Optician based in Bristol, UK, has announced his fears that many of the young people of today will undoubtedly be suffering from vision problems by the time they reach middle-age due to the emitted light from various technological sources and also eco -friendly lighting which many of us have now been persuaded to use throughout our homes and workplaces |
Lucentis Competition?A leading product produced by Ohr Pharmaceutical has been used in tests against a placebo for mid-stage trials in patients with age related macular degeneration, still the leading cause of blindness in our pensioners and elderly worldwide.The licensed drug currently used for treatment of AMD is Lucentis. |